Janux Therapeutics (JANX) PT Lowered to $80 at Truist Securities Mar 3, 2026 09:20AM
Janux Therapeutics, Inc. (JANX) Tops Q4 EPS by 11c Feb 26, 2026 05:20PM
Clear Street Downgrades Janux Therapeutics (JANX) to Hold Jan 20, 2026 05:14AM
Truist on Janux Therapeutics (JANX): 'The Post-Market Selloff Appears Overblown' Dec 2, 2025 09:25AM
Janux Therapeutics (JANX) Reiterated at Buy by UBS After JANX007 Ph1 update Dec 2, 2025 07:40AM


Dec 2, 2025 07:29AM Janux Therapeutics (JANX) PT Lowered to $150 at Cantor Fitzgerald
Dec 2, 2025 06:40AM Janux Therapeutics (JANX) PT Lowered to $45 at H.C. Wainwright
Dec 2, 2025 05:28AM Janux Therapeutics (JANX) PT Lowered to $49 at BofA Securities
Dec 2, 2025 04:28AM Janux Therapeutics (JANX) PT Lowered to $38 at Stifel
Dec 1, 2025 04:32PM After-hours movers: MongoDB, Instacart, Iris Energy, Credo Technology and more
Nov 17, 2025 04:13PM Wolfe Research Starts Janux Therapeutics (JANX) at Peerperform
Nov 11, 2025 01:40PM Janux Therapeutics (JANX) PT Lowered to $65 at Jones Trading
Nov 6, 2025 06:28PM Janux Therapeutics, Inc. (JANX) Tops Q3 EPS by 23c
Oct 4, 2025 04:00PM Why UBS says Q4 is eventful for SMID oncology stocks
Sep 17, 2025 04:34AM Barclays Starts Janux Therapeutics (JANX) at Overweight
Sep 10, 2025 06:10AM Truist Securities Starts Janux Therapeutics (JANX) at Buy
Sep 10, 2025 02:00AM Stifel Resumes Janux Therapeutics (JANX) at Buy
Sep 4, 2025 05:43AM Guggenheim Starts Janux Therapeutics (JANX) at Buy
Aug 19, 2025 06:15AM Piper Sandler Starts Janux Therapeutics (JANX) at Overweight
Jul 25, 2025 07:39AM Cantor Fitzgerald Reiterates Overweight Rating on Janux Therapeutics (JANX)
Jul 11, 2025 06:24AM Raymond James Starts Janux Therapeutics (JANX) at Outperform
May 28, 2025 04:25AM Citizens JMP shares updates on cancer treatment stocks
May 12, 2025 06:19AM Janux Therapeutics (JANX) PT Lowered to $89 at Leerink Partners
May 9, 2025 04:39PM Janux Therapeutics, Inc. (JANX) Misses Q1 EPS by 1c
May 5, 2025 08:31AM Janux Therapeutics (JANX) initiates expansion Phase 1b studies for JANX007
Feb 28, 2025 07:34AM Cantor Fitzgerald Reiterates Overweight Rating on Janux Therapeutics (JANX)
Jan 24, 2025 04:02PM Janux Therapeutics (JANX) Appoints Zachariah McIver as Chief Medical Officer
Jan 10, 2025 06:09AM BTIG Reiterates Buy Rating on Janux Therapeutics (JANX)
Dec 12, 2024 01:17PM Clear Street Starts Janux Therapeutics (JANX) at Buy
Dec 5, 2024 06:05AM Janux Therapeutics (JANX) Prices 5.32M Share Offering at $63/sh
Dec 4, 2024 07:13AM Janux Therapeutics (JANX) PT Raised to $62 at Scotiabank
Dec 3, 2024 04:02PM Janux Therapeutics (JANX) Announces Proposed $300M Share Offering
Dec 3, 2024 12:25PM Janux Therapeutics (JANX) PT Raised to $105 at Jones Trading
Dec 3, 2024 08:50AM TD Cowen Reiterates Buy on Janux Therapeutics (JANX) as JANX007 'Far Exceeds High Expectations'
Dec 3, 2024 08:22AM Janux Therapeutics (JANX) PT Raised to $115 at Stifel
Dec 3, 2024 07:06AM William Blair on Janux Therapeutics (JANX): 'Exceeding Investor Expectations and Raising the Bar in mCRPC'
Dec 3, 2024 06:55AM Janux Therapeutics (JANX) PT Raised to $91 at Leerink Partners
Dec 3, 2024 06:45AM Janux Therapeutics (JANX) PT Raised to $70 at H.C. Wainwright
Dec 3, 2024 06:32AM Janux Therapeutics (JANX) PT Raised to $200 at Cantor Fitzgerald, 'Mic Drop - '007 HRPC Update Waaayyy Above Expectations'
Dec 3, 2024 05:30AM Janux Therapeutics (JANX) call put ratio 1 call to 2.8 puts into data
Dec 3, 2024 05:27AM Stifel Reiterates Buy Rating on Janux Therapeutics (JANX)
Dec 3, 2024 05:26AM Janux Therapeutics (JANX) PT Raised to $100 at BTIG, 'The World Is Not Enough — 007 Strikes Again Exceeding The Street's Highest Expectations'
Dec 2, 2024 04:41PM Vir Biotechnology (VIR) Trades Higher in Sympathy with Janux Therapeutics (JANX)
Dec 2, 2024 04:40PM Janux Therapeutics (JANX) Surges 40% After Encouraging Efficacy and Safety Profile Observed in Phase 1a Dose Escalation for JANX007 in mCRPC
Dec 2, 2024 04:38PM After-hours movers: Zscaler, Honeywell, Microchip Technology and more
Dec 2, 2024 04:34PM Janux Therapeutics (JANX) Announces Doses Selected for Phase 1b Expansion Trials Supported by Encouraging Efficacy and Safety Profile Observed in Phase 1a Dose Escalation for JANX007 in mCRPC
Nov 22, 2024 06:28AM Leerink Partners Starts Janux Therapeutics (JANX) at Outperform
Nov 7, 2024 09:03AM Janux Therapeutics, Inc. (JANX) Misses Q3 EPS by 18c
Oct 24, 2024 03:54AM UBS Starts Janux Therapeutics (JANX) at Buy
Sep 5, 2024 04:07PM Stifel Starts Janux Therapeutics (JANX) at Buy
Aug 19, 2024 06:50AM H.C. Wainwright Reiterates Buy Rating on Janux Therapeutics (JANX)
Aug 9, 2024 07:04AM Janux Therapeutics (JANX) PT Lowered to $42 at Scotiabank
Aug 8, 2024 03:47AM Janux Therapeutics, Inc. (JANX) Tops Q2 EPS by 20c
Jul 22, 2024 04:01PM Janux Therapeutics (JANX) Announces Updates to Board of Directors